Table 1.
Summary of clinical data of patients included in the study.
| Diagnosis | OA (n = 42) | RA (n = 36) |
|---|---|---|
| Age (mean years ± SEM), (range) | 57.3 ± 1.3 (34–70) | 51.8 ± 2 (24–71) |
| Gender | 29F/13M | 26F/10M |
| ESR (range) | 13 ± 1.2 (2–37) | 32.6 ± 2.8 (3–58) |
| Disease duration (mean years ± SEM), (range) | Data not available | 20.6 ± 1.7 (7–50) |
| Treatment | ||
| NSAID: | ||
| Meloxicam | 1 | N/A |
| Diclofenac | 13 | 19 |
| Ketoprofen | 2 | N/A |
| Nimesulid | 1 | N/A |
| Naproxen | 1 | N/A |
| Not-NSAID: | ||
| Paracetamol | 8 | N/A |
| Tramadol | 4 | N/A |
| Paracetamol + Tramadol | 1 | 1 |
| DMARD: | ||
| Methotrexate | N/A | 11 |
| Sulfasalazine | N/A | 3 |
| Leflunomide | N/A | 2 |
| Azathioprine | N/A | 1 |
| Steroids: | ||
| Methylprednisolone | N/A | 21 |
| Encorton | N/A | 9 |